To study the efficacy of extended-release Urocitra in patients with observing intact pills in feces

Phase 3

Recruiting

• Conditions: Renal stone.; Encounter for examination for normal comparison and control in clinical research program; Z00.6

• Registration Number: IRCT20191026045244N4
• Lead Sponsor: Sobhan darou Co

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Urolithiasis patients with and without observing extended release Urocitra in feces

Exclusion Criteria

chronic kidney disease (stage 3&4)
pregnancy or lactation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
24-hour urine citrate. Timepoint: after 4 weeks treatment with Extended-release Urocitra. Method of measurement: 24- hour urine citrat measurment (enzymatic), mg/day.;Urine pH. Timepoint: after 4 weeks treatment with Extended-release Urocitra. Method of measurement: Measurement of fresh urine pH by pH meter.;Investigation of the possibility of recurrence of observing intact pills in the feces of patients with previous proclem. Timepoint: After four weeks. Method of measurement: Questionnaire.